Table 1. Patient Characteristics Patient... | American Society of Hematology

Table 1.

Patient Characteristics

Patient ID	Sex/Age	Treatment	% CD19⁺/ CD11c⁺ Cells	bFGF pg/mL^†
K.M.	F/81	None	1	1
S.A.	M/59	IFN-α	1	6
S.G.	M/55	G-CSF	2	12
H.J.	M/61	None	9	27
H.H.	M/67	None	49	53
S.K.	M/46	IFN-α	80	16
S.L.	F/84	IFN-α	84	90
Mean values	64			29.3
HD (n = 7)	5 M/2 F 39		<1	0.8

Patient ID	Sex/Age	Treatment	% CD19⁺/ CD11c⁺ Cells	bFGF pg/mL^†
K.M.	F/81	None	1	1
S.A.	M/59	IFN-α	1	6
S.G.	M/55	G-CSF	2	12
H.J.	M/61	None	9	27
H.H.	M/67	None	49	53
S.K.	M/46	IFN-α	80	16
S.L.	F/84	IFN-α	84	90
Mean values	64			29.3
HD (n = 7)	5 M/2 F 39		<1	0.8

Abbreviations: G-CSF, granulocyte colony-stimulating factor; IFN, interferon.

Peripheral blood mononuclear cells.

bFGF levels in serum.